GHP Investment Advisors Inc. Acquires 360 Shares of DaVita Inc. (NYSE:DVA)

GHP Investment Advisors Inc. raised its holdings in shares of DaVita Inc. (NYSE:DVA) by 0.8% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 45,306 shares of the company’s stock after purchasing an additional 360 shares during the period. GHP Investment Advisors Inc.’s holdings in DaVita were worth $6,278,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in DVA. Blue Trust Inc. increased its stake in shares of DaVita by 58.6% during the second quarter. Blue Trust Inc. now owns 211 shares of the company’s stock valued at $29,000 after purchasing an additional 78 shares in the last quarter. Newbridge Financial Services Group Inc. bought a new position in shares of DaVita during the fourth quarter valued at approximately $30,000. Principal Securities Inc. purchased a new stake in shares of DaVita during the fourth quarter valued at approximately $37,000. Family Firm Inc. purchased a new stake in shares of DaVita during the second quarter valued at approximately $43,000. Finally, Versant Capital Management Inc grew its holdings in shares of DaVita by 90.6% during the second quarter. Versant Capital Management Inc now owns 326 shares of the company’s stock valued at $45,000 after buying an additional 155 shares during the last quarter. Institutional investors own 90.12% of the company’s stock.

DaVita Stock Up 3.8 %

Shares of DVA stock opened at $163.56 on Friday. The company has a market capitalization of $14.34 billion, a price-to-earnings ratio of 18.59, a PEG ratio of 0.88 and a beta of 0.87. DaVita Inc. has a one year low of $71.51 and a one year high of $163.59. The company’s fifty day moving average price is $145.17 and its 200-day moving average price is $139.83. The company has a debt-to-equity ratio of 9.94, a current ratio of 1.16 and a quick ratio of 1.12.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $2.59 EPS for the quarter, beating the consensus estimate of $2.47 by $0.12. The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.15 billion. DaVita had a net margin of 6.86% and a return on equity of 77.00%. The company’s revenue was up 6.2% on a year-over-year basis. During the same period last year, the firm earned $2.08 EPS. Sell-side analysts expect that DaVita Inc. will post 9.99 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

DVA has been the topic of a number of recent analyst reports. StockNews.com cut shares of DaVita from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 8th. TD Cowen increased their price target on shares of DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a report on Wednesday, July 24th. Truist Financial increased their price target on shares of DaVita from $150.00 to $165.00 and gave the company a “hold” rating in a report on Tuesday, August 20th. Bank of America increased their price target on shares of DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a report on Wednesday, August 7th. Finally, UBS Group increased their price target on shares of DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a report on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, DaVita presently has a consensus rating of “Hold” and an average target price of $157.00.

Insider Activity

In other news, insider Kathleen Alyce Waters sold 7,857 shares of the firm’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the sale, the insider now directly owns 83,011 shares in the company, valued at approximately $12,137,038.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other DaVita news, COO Michael David Staffieri sold 9,539 shares of DaVita stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $150.03, for a total value of $1,431,136.17. Following the sale, the chief operating officer now directly owns 241,945 shares in the company, valued at approximately $36,299,008.35. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Kathleen Alyce Waters sold 7,857 shares of DaVita stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the completion of the sale, the insider now owns 83,011 shares in the company, valued at $12,137,038.31. The disclosure for this sale can be found here. Insiders have sold 113,601 shares of company stock worth $17,525,449 in the last three months. Company insiders own 2.00% of the company’s stock.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.